Hyperhomocysteinaemia, Low Folate Concentrations and Methylene Tetrahydrofolate Reductase C677T Mutation in Acute Mesenteric Venous Thrombosis

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 4, 2010, Pages 508-513

  He, J A ^a   Hu, X H ^a   Fan, Y Y ^a   Yang, J ^a   Zhang, Z S ^a   Liu, C W ^b   Yang, D H ^a   Zhang, J ^a   Xin, S J ^a   Zhang, Q ^a   Duan, Z Q ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Acute mesenteric venous thrombosis; Folate; Gene mutation; Hyperhomocysteinaemia; Methylene tetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE MUTATION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ACUTE DISEASE; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOWN-REGULATION; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; MALE; MESENTERIC VASCULAR OCCLUSION; MESENTERIC VEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS; VITAMIN B 12; YOUNG ADULT;

EID: 77950031190     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.09.014     Document Type: Article

References (34)

1. Warren S., and Eberhardt T.P. Mesenteric venous thrombosis. Surg Gynecol Obstet 61 (1935) 102-120
2. Kumar S., Sarr M.G., and Kamath P.S. Mesenteric venous thrombosis. N Engl J Med 345 (2001) 1683-1688
3. Eliot J.W. The operative relief of gangrene of the intestine due to occlusion of the mesenteric vessels. Ann Surg 21 (1895) 9-23
4. Zhang J., Duan Z.Q., Song Q.B., Luo Y.W., Xin S.J., and Zhang Q. Acute mesenteric venous thrombosis: a better outcome achieved through improved imaging techniques and a changed policy of clinical management. Eur J Vasc Endovasc Surg 28 (2004) 329-334
5. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
6. 6 are independently associated with a heightened risk of deep-vein thrombosis. Circulation 104 (2001) 2442-2446
7. Fermo I., Vigano S., Paroni R., Mazzola G., Calori G., and D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial thrombosis. Ann Intern Med 123 (1995) 747-753
8. den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., and Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80 (1998) 874-877
9. Wuillemin W.A., and Solenthaler M. Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis. Vasa 28 (1999) 151-155
10. den Heljer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334 (1996) 759-762
11. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 288 (2002) 2015-2022
12. Falcon C.R., Cattaneo M., Panzeri D., Martinelli I., and Mannucci P.M. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb Vasc Biol 14 (1994) 1080-1083
13. den Heijer M., Blom H.J., Gerrits W.B.J., Rosendaal F.R., and Haak H.L. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?. Lancet 345 (1995) 882-885
14. Simioni P., Prandoni P., Burlina A., Tormene D., Sardella C., Ferrari V., et al. Hyperhomocysteinemia and deep-vein thrombosis: a case control study. Thromb Haemost 76 (1996) 883-886
15. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158 (1998) 2101-2106
16. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81 (1999) 165-176
17. Kang S.S., Wong P.W., Zhou J.M., Sora J., Lessick M., Ruggie N., et al. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabol 37 (1988) 611-613
18. Cattaneo M., Tsai M.Y., Bucciarelli P., Taioli E., and Zighetti M.L. Bignell reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V: Q506). Arterioscler Thromb Vasc Biol 17 (1997) 1662-1666
19. Kluijtmans L.A., van den Heuvel L.P., Boers G.H., Frosst P., Stevens E.M., van Oost B.A., et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58 (1996) 35-41
20. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., and Costa F.F. The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 77 (1997) 818-821
21. Hsu T., Hsu L., Chang C., Sun C., Ko Y., Kuo C., et al. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study. Thromb Res 102 (2001) 387-395
22. Weger M., Stanger O., and Haas A. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 131 (2001) 290-291
23. Langman L.J., Ray J.G., Evrovski J., Yeo E., and Cole D.E. Hyperhomocyst(e) inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch Intern Med 160 (2000) 961-964
24. Fryer R.H., Wilson B.D., Gubler D.B., Fitzgerald L.A., and Rodgers G.-M. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13 (1993) 1327-1333
25. Rodgers G.M., and Conn M.T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75 (1990) 895-901
26. Harpel P.C., Zhang X., and Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 126 Suppl. 4 (1996) 1285S-1289S
27. Gatt A., and Markris M. Hyperhomocysteinemia and venous thrombosis. Semin Hematol 44 (2007) 70-76
28. Ho C.H., Kuo B.I., Kong C.W., Chau W.K., Hsu H.C., Gau J.P., et al. Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese. J Chin Med Assoc 68 (2005) 560-565
29. 12 in puerperal cerebral venous thrombosis. Neurol Sci 272 (2008) 43-47
30. Acosta S., Alhadad A., Svensson P., and Ekberg O. Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 95 (2008) 1245-1251
31. Preter M., Tzourio C., Ameri A., and Bousser M.G. Longterm prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 27 (1996) 243-246
32. Martinelli I., Battaglioli T., Pedotti P., Cattaneo M., and Mannucci P.M. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 102 (2003) 1363-1366
33. Hoţoleanu C., Porojan-Iuga M., Rusu M.L., and Andercou A. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis. Rom J Intern Med 45 (2007) 159-164
34. 12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 35 (2004) 1790-1794